抗癌疗法的前沿进展：来自特刊《新型抗癌策略》第三版的见解
Cutting-Edge Advances in Anticancer Therapies: Insights from the Third Edition of the Special Issue "Novel Anticancer Strategies".
作者信息
Bousbaa Hassan
机构信息
UNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.
出版信息
Pharmaceutics. 2025 Jan 3;17(1):54. doi: 10.3390/pharmaceutics17010054.
Abstract
Cancer incidence and mortality continue to rise at an alarming rate worldwide, underscoring the urgent need for more effective therapeutic interventions [...].
摘要
全球范围内，癌症发病率和死亡率持续以惊人的速度上升，这凸显了对更有效治疗干预措施的迫切需求[……]。
相似文献
1
Cutting-Edge Advances in Anticancer Therapies: Insights from the Third Edition of the Special Issue "Novel Anticancer Strategies".抗癌疗法的前沿进展：来自特刊《新型抗癌策略》第三版的见解
Pharmaceutics. 2025 Jan 3;17(1):54. doi: 10.3390/pharmaceutics17010054.
2
Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy.用于增强大黄素在癌症治疗中疗效的纳米药物递送系统的进展
Int J Pharm X. 2024 Dec 25;9:100314. doi: 10.1016/j.ijpx.2024.100314. eCollection 2025 Jun.
3
Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions.小细胞肺癌DLL3靶向治疗的进展：挑战、机遇与未来方向。
Front Oncol. 2024 Dec 5;14:1504139. doi: 10.3389/fonc.2024.1504139. eCollection 2024.
4
Advancements in the Treatment of Atherosclerosis: From Conventional Therapies to Cutting-Edge Innovations.动脉粥样硬化治疗的进展：从传统疗法到前沿创新
ACS Pharmacol Transl Sci. 2024 Dec 4;7(12):3804-3826. doi: 10.1021/acsptsci.4c00574. eCollection 2024 Dec 13.
5
Natural Products/Bioactive Compounds as a Source of Anticancer Drugs.天然产物/生物活性化合物作为抗癌药物的来源。
Cancers (Basel). 2022 Dec 15;14(24):6203. doi: 10.3390/cancers14246203.
6
Editorial Commentary on the Special Issue "Antioxidant Therapy for Cardiovascular Diseases"-Cutting-Edge Insights into Oxidative Stress and Antioxidant Therapy in Cardiovascular Health.关于“心血管疾病的抗氧化治疗——心血管健康中氧化应激与抗氧化治疗的前沿见解”特刊的社论评论
Antioxidants (Basel). 2024 Aug 26;13(9):1034. doi: 10.3390/antiox13091034.
7
Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?姜黄素作为一种新型癌症治疗候选药物：这种天然化合物能否彻底改变癌症治疗方式？
Front Oncol. 2024 Oct 23;14:1438040. doi: 10.3389/fonc.2024.1438040. eCollection 2024.
8
Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects.帕金森病中的维 A 酸：分子见解、治疗进展和未来前景。
Life Sci. 2024 Oct 15;355:123010. doi: 10.1016/j.lfs.2024.123010. Epub 2024 Aug 23.
9
Editorial for the Special Issue "Advances in the Development of Anticancer Drugs".专刊编辑按语：“抗癌药物研发进展”特刊
Int J Mol Sci. 2024 Jan 4;25(1):641. doi: 10.3390/ijms25010641.
10
Editor's Introduction to Special Issue on Enhancing Prehospital Care for Patients with Opioid Use Disorder.编者对改善阿片类药物使用障碍患者院前护理特刊的介绍。
Prehosp Emerg Care. 2025;29(4):323-324. doi: 10.1080/10903127.2025.2496231. Epub 2025 Jun 3.
本文引用的文献
1
miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses.微小RNA介导的有效且安全的溶瘤病毒产生机制
Pharmaceutics. 2024 Jul 25;16(8):986. doi: 10.3390/pharmaceutics16080986.
2
Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles.结肠癌中的天然查尔酮及其衍生物：临床前挑战与基于查尔酮的纳米颗粒的前景
Pharmaceutics. 2023 Dec 1;15(12):2718. doi: 10.3390/pharmaceutics15122718.
3
Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer.AZD3965抑制乳酸转运对肌层浸润性尿路上皮膀胱癌的影响。
Pharmaceutics. 2023 Nov 28;15(12):2688. doi: 10.3390/pharmaceutics15122688.
4
Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs.释放合成致死性的力量：通过与化疗药物的协同整合提高治疗效果。
Pharmaceutics. 2023 Oct 8;15(10):2433. doi: 10.3390/pharmaceutics15102433.
5
RNAi-Mediated Knockdown of Cottontail Rabbit Papillomavirus Oncogenes Using Low-Toxicity Lipopolyplexes as a Paradigm to Treat Papillomavirus-Associated Cancers.以低毒性脂质多聚体介导RNA干扰敲除棉尾兔乳头瘤病毒癌基因作为治疗乳头瘤病毒相关癌症的范例
Pharmaceutics. 2023 Sep 25;15(10):2379. doi: 10.3390/pharmaceutics15102379.
6
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using Lu-iPSMA and Lu-DOTATOC: Experience after 905 Treatment Doses.使用镥标记的前列腺特异性膜抗原（Lu-iPSMA）和镥标记的奥曲肽（Lu-DOTATOC）改善前列腺癌和神经内分泌肿瘤患者的总生存期和生活质量：905次治疗剂量后的经验
Pharmaceutics. 2023 Jul 20;15(7):1988. doi: 10.3390/pharmaceutics15071988.
7
Multifunctional Polymeric Biodegradable and Biocompatible Coatings Based on Silver Nanoparticles: A Comparative In Vitro Study on Their Cytotoxicity towards Cancer and Normal Cell Lines of Cytostatic Drugs versus Essential-Oil-Loaded Nanoparticles and on Their Antimicrobial and Antibiofilm Activities.基于银纳米颗粒的多功能可生物降解且生物相容的聚合物涂层：关于其对癌症和正常细胞系的细胞毒性（与细胞毒性药物相比，负载精油的纳米颗粒对其）以及抗菌和抗生物膜活性的体外比较研究。
Pharmaceutics. 2023 Jul 4;15(7):1882. doi: 10.3390/pharmaceutics15071882.
8
Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment.响应组织蛋白酶B活性的癌症治疗智能递送系统
Pharmaceutics. 2023 Jun 29;15(7):1848. doi: 10.3390/pharmaceutics15071848.
9
The Exploitation of Lysosomes in Cancer Therapy with Graphene-Based Nanomaterials.基于石墨烯的纳米材料在癌症治疗中对溶酶体的利用
Pharmaceutics. 2023 Jun 28;15(7):1846. doi: 10.3390/pharmaceutics15071846.
10
Development of pH-Responsive Hyaluronic Acid-Conjugated Cyclodextrin Nanoparticles for Chemo-/CO-Gas Dual Therapy.用于化学/一氧化碳气体联合治疗的pH响应性透明质酸共轭环糊精纳米颗粒的研发
Pharmaceutics. 2023 Jun 25;15(7):1818. doi: 10.3390/pharmaceutics15071818.
Zotero 插件